A novel bispecific antibody targeting two overlapping epitopes in RBD improves neutralizing potency and breadth against SARS-CoV-2-Reference-Cited by-同舟云学术

A novel bispecific antibody targeting two overlapping epitopes in RBD improves neutralizing potency and breadth against SARS-CoV-2

Published:2024-07-12 Issue:1 Volume:13 Page:
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Sun Hancong¹,Xia Lingyun²,Li Jianhua³,Zhang Yuanyuan²,Zhang Guanying¹,Huang Ping¹,Wang Xingxing³,Cui Yue¹,Fang Ting¹,Fan Pengfei¹,Zhou Qiang²,Chi Xiangyang¹,Yu Changming¹

Affiliation:

1. Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, People’s Republic of China

2. Center for Infectious Disease Research, Research Center for Industries of the Future, Zhejiang Key Laboratory of Structural Biology, School of Life Sciences, Westlake University, Institute of Biology, Westlake Institute for Advanced Study, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang Province, People’s Republic of China

3. Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Key Laboratory of Public Health Detection and Etiological Research of Zhejiang Province, Hangzhou, Zhejiang Province, People’s Republic of China

Funder

Hangzhou agricultural and social development scientific research project

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2024.2373307

Reference48 articles.

1. A pneumonia outbreak associated with a new coronavirus of probable bat origin

2. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

3. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

4. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7

5. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera